The frequency and duration of side-effects associated with the use of oral metronidazole; A prospective study of VITA trial participants

Oluseyi Ayinde; Jonathan D.C. Ross

doi:10.1177/09564624231179505

The frequency and duration of side-effects associated with the use of oral metronidazole; A prospective study of VITA trial participants

Oluseyi Ayinde^*
, Jonathan D.C. Ross

^*Corresponding author for this work

University Hospitals Birmingham NHS Foundation Trust

Research output: Contribution to journal › Article › peer-review

15 Citations (SciVal)

Original language	English
Pages (from-to)	897-902
Number of pages	6
Journal	International Journal of STD and AIDS
Volume	34
Issue number	12
DOIs	https://doi.org/10.1177/09564624231179505
Publication status	Published (VoR) - Oct 2023

Funding

The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The VITA trial was funded by the Health Technology Assessment Programme (HTA Project ID: 15/110/02) and registered prior to start of recruitment (ISRCTN14161293). The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care. The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The VITA trial was funded by the Health Technology Assessment Programme (HTA Project ID: 15/110/02) and registered prior to start of recruitment (ISRCTN14161293). The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care.

Keywords

Antibiotic
adverse drug event
treatment

Access to Document

10.1177/09564624231179505

Cite this

@article{78f51a539e3e4ff2ab36368ee166be6f,

title = "The frequency and duration of side-effects associated with the use of oral metronidazole; A prospective study of VITA trial participants",

keywords = "Antibiotic, adverse drug event, treatment",

author = "Oluseyi Ayinde and Ross, \{Jonathan D.C.\}",

note = "Funding Information: The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The VITA trial was funded by the Health Technology Assessment Programme (HTA Project ID: 15/110/02) and registered prior to start of recruitment (ISRCTN14161293). The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care. Publisher Copyright: {\textcopyright} The Author(s) 2023.",

year = "2023",

month = oct,

doi = "10.1177/09564624231179505",

language = "English",

volume = "34",

pages = "897--902",

journal = "International Journal of STD and AIDS",

issn = "0956-4624",

publisher = "SAGE Publications",

number = "12",

}

TY - JOUR

T1 - The frequency and duration of side-effects associated with the use of oral metronidazole; A prospective study of VITA trial participants

AU - Ayinde, Oluseyi

AU - Ross, Jonathan D.C.

N1 - Funding Information: The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The VITA trial was funded by the Health Technology Assessment Programme (HTA Project ID: 15/110/02) and registered prior to start of recruitment (ISRCTN14161293). The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care. Publisher Copyright: © The Author(s) 2023.

PY - 2023/10

Y1 - 2023/10

KW - Antibiotic

KW - adverse drug event

KW - treatment

UR - https://www.scopus.com/pages/publications/85164504082

UR - https://www.scopus.com/pages/publications/85164504082#tab=citedBy

U2 - 10.1177/09564624231179505

DO - 10.1177/09564624231179505

M3 - Article

C2 - 37395087

AN - SCOPUS:85164504082

SN - 0956-4624

VL - 34

SP - 897

EP - 902

JO - International Journal of STD and AIDS

JF - International Journal of STD and AIDS

IS - 12

ER -

The frequency and duration of side-effects associated with the use of oral metronidazole; A prospective study of VITA trial participants

Funding

Keywords

Access to Document

Other files and links

Fingerprint

Cite this